Xi Wang

2.4k citations
110 papers · 1.6k indexed · 1 hit paper · h-index 22

Xi Wang

99 papers receiving 1.6k citations

Hit Papers

Increased glucose metabolism in TAMs fuels O-GlcNAcylatio...214202220262023202450100150200

Peers

Xi Wang
Comparison fields: 5 of 138
  • Biomaterials 234
  • Molecular Medicine 65
  • Immunology 251
  • Biomedical Engineering 330
  • Polymers and Plastics 104
Replace Xinke Zhang with:
Xinke Zhang China
Magdalena Skonieczna Poland
Jiawei Guo China
Ying Tu China
Jiaxin Wang China
Rongrong Wang China
Yuxuan Zhu China
Huiting Zhou China
Lili Qin China
Xi Wang relative to Xinke Zhang China Xinke Zhang's profile →
Citations per field
00.5×1.5×2.3×
Xinke Zhang · 1×
Citations per year

Countries citing papers authored by Xi Wang

Since Specialization
Citations

This map shows the geographic impact of Xi Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xi Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xi Wang more than expected).

Fields of papers citing papers by Xi Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xi Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xi Wang. The network helps show where Xi Wang may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Xi Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Xi Wang Line = papers co-authored together Xi Wang links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20250
2 20253
3 20244
4 20242
5 20244
6 20241
7 202310
8 20237
9 202312
10 202323
11 20234
12 202316
13 20232
14 202314
15 20231
16 20220
17 20221
18 201916
19 20182
20
Antihypoxic Effect of Orientoside on Hypoxia Model Mice
20062

About Xi Wang

Xi Wang is a scholar working on Biomaterials, Complementary and alternative medicine and Polymers and Plastics, having authored 110 papers that have together received 1.6k indexed citations. Recurring topics across this work include Immune cells in cancer (8 papers), Nanoparticle-Based Drug Delivery (7 papers), Graphene and Nanomaterials Applications (5 papers), Dendrimers and Hyperbranched Polymers (5 papers), Electrospun Nanofibers in Biomedical Applications (5 papers), Antimicrobial agents and applications (5 papers), Advanced Polymer Synthesis and Characterization (5 papers) and Polymer Surface Interaction Studies (5 papers). The work is most often cited by research in Biomaterials (234 citations), Molecular Medicine (65 citations) and Immunology (251 citations). Xi Wang has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Fei Tian, Jian Yang, Kui Lin, Fangli Yuan, Peng Hu, Jian Yang, Yanfang Liu, Zhaoyun Liu, Hao Wang and Qian Zhang. Their work appears in journals such as International Journal of Biological Macromolecules, Journal of Colloid and Interface Science, Journal of Food Composition and Analysis, Frontiers in Immunology and Journal of Pharmaceutical and Biomedical Analysis.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026